|
|
|
|
|
|
|
|
|
|||
|
|
|
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
    |
|
Investor RelationsOn these pages you will find the articles and by-laws of the company as well as current information regarding Sangui share price. In order to facilitate information processes for our shareholders the frequently asked questions section ("FAQ") will not only contain basic information but will also be updated on a regular basis. On the page Share History you will find an overview of changes in Stockholders' Equity since the inception of the company in 1996. The overview will be updated after the filing of our 2009 report on form 10-KSB. Please refer to our Corporate Presentation for more details about the status of our wound management activities, Please note, that Sangui continues to be a high risk investment. Investors should be aware of the risk sections included in our recent SEC filings. Comprehensive risk information is contained in the risk memorandum avalailable for download here.
No. of Sangui shares issued and outstanding: approx. 68 million No. of Sangui shares authorized: 250,000,000 common stock, 10,000,000 preferred stock Cusip No.: 80105B101 ISIN: US80105B1017 Traded: www.pinksheets.com (symbol: SGBI) WKN: 906757 Traded: OTC market in Hamburg (Symbol: SBH) |
|
|||
|
|